From Biomaterials to Polymers: Aging Models, Fatigue Simulation, and Finite Element Analysis of Valve Leaflets – Dr. Dikai Chen at DCF2024
Kokai Life Sciences
Developer, Manufacturer, and Distributor in the Field of Structural Heart Disease
The 2024 Suzhou Municipal Continuing Medical Education Project "Frontiers and Hotspots in Cardiovascular Diseases" and the Dushu Lake Yangtze River Delta Cardiology Conference (DCF2024), jointly organized by the Oriental Huaxia Cardiovascular Health Research Institute of Suzhou Industrial Park, Beijing Health Promotion Association, and the Fourth Affiliated Hospital of Suzhou University (Suzhou Dushu Lake Hospital), will be grandly held from December 6 to December 8, 2024, at the Suzhou Four Points by Sheraton Hotel. The conference will take place both online and offline. Focusing on the hot topics and challenges in cardiovascular diseases, this meeting aims to closely integrate basic and clinical research, targeting frontline cardiovascular clinicians with thematic academic activities. The content of this conference covers key areas such as coronary heart disease, cardiac electrophysiology and pacing, hypertension, and heart failure.
1
Chen Dakai Delivers Speech
Title: "From Biomaterials to Polymeric Materials—Aging Models, Fatigue Simulations, and Finite Element Analysis of Valve Leaflets"
Finite element technology is widely used in the field of artificial valves, aiming to achieve mechanical properties close to or reaching those of human heart valves. This technology conducts detailed theoretical analysis on the geometric design methods of the valves and compares the stress distribution of valve leaflets in different shapes, providing a solid theoretical foundation for the design and manufacture of biological valves.
Chen Dakai provided a detailed introduction to the process of finite element analysis, the types and characteristics of finite element FEA software, the limitations of finite element FEA analysis, the future development direction of finite element FEA analysis, and the characteristics of finite element analysis for polymer valves.
In summary, the proper application of finite element technology will significantly enhance the efficiency and outcomes of valve development.
The conference concluded successfully.
During the conference, frontline clinical cardiologists from across China actively participated in thematic discussions, exchanged academic insights in depth, and shared treatment experiences. In this process, participants jointly promoted the development of cardiovascular medicine, expanded academic perspectives, and explored more innovative treatment methods and technologies. Through comprehensive communication and sharing, participants not only enhanced their professional competence during continuous learning but also deepened their understanding of the challenges and opportunities in the current cardiovascular field, further advancing the development of cardiovascular disciplines. The successful hosting of this conference also strengthened communication and cooperation among peers, laying a solid foundation for future clinical practice and scientific research innovation.
1
About Kokai
ABOUT KOKA
Kokai (Nantong) Life Sciences Co., Ltd. was established in September 2018. It is a high-end biopharmaceutical technology enterprise that integrates the research and development, production, and sales of medical devices in the field of structural heart disease, developing systematic solutions for valve diseases targeting different populations, needs, and scenarios. The company's technical team is primarily composed of R&D personnel who have returned from the United States and Germany, possessing years of development and research experience in cardiac medicine. Their technical level is leading in China and is synchronized with advanced global frontiers in cardiac medical treatment.
The company has been honored with:
2024 Hurun China Medical New Forces Enterprises
Hurun Global Gazelle Companies 2023
Top 100 Emerging Medical Device Companies in China 2023
2023 Future Healthcare 100 Strong List "Top 100 China Innovative Medical Devices"
2022 Annual Outstanding Contribution to Scientific Innovation Award in the City North High-Tech Zone – Innovation Star
2022 KPMG China's Second Biotech Innovation 50
2022 China Investment Medical Health VENTURE50 List
Top 10 Most Growth-Oriented Innovative Medical Device Companies in China's Biomedical Science and Technology Innovation Value List 2022
Top 10 Most Growth-Oriented New Economy Enterprises in China's Healthcare Sector in 2022 by China Venture Capital
List of Potential Unicorn Companies in Jiangsu Province, 2022
2021 GEI List of Potential Unicorn Companies in China
Selected as one of the top 100 innovative medical device companies in China by the Zhong Nanshan Medical Foundation and other organizations in 2021
2020 GEI List of Potential Unicorn Companies in China